<unk> (oral) is a dopamine antagonist that is FDA approved for the treatment of schizophrenia, bipolar mania, irritability associated with autistic disorder. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include increased mortality in elderly patients with dementia-related psychosis, cerebrovascular adverse events, including stroke, in elderly patients with dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia , metabolic Changes (hyperglycemia and diabetes mellitus, dyslipidemia, weight gain), hyperprolactinemia, orthostatic hypotension, leukopenia, neutropenia, agranulocytosis, potential for cognitive and motor impairment, seizures, dysphagia, priapism, disruption of body temperature regulation.
Risperidone 
Aripiprazole 
Methylphenidate 
Olanzapine 
Ziprasidone 
Noscapine
Sertraline
Dexmethylphenidate